Resistance to store depletion-induced endothelial injury in rat lung after chronic heart failure

Am J Respir Crit Care Med. 2005 Nov 1;172(9):1153-60. doi: 10.1164/rccm.200506-847OC. Epub 2005 Jul 28.

Abstract

Rationale: In chronic heart failure, the lung endothelial permeability response to angiotensin II or thapsigargin-induced store depletion is ablated, although the mechanisms are not understood.

Objectives: To determine whether the ablated permeability response to store depletion during heart failure was due to impaired expression of store operated Ca2+ channels in lung endothelium.

Methods: Heart failure was induced by aortocaval fistula in rats. Permeability was measured in isolated lungs using the filtration coefficient and a low Ca2+/Ca2+ add-back strategy to identify the component of the permeability response dependent on Ca2+ entry.

Main results: In fistulas, right ventricular mass and left ventricular end diastolic pressure were increased and left ventricular shortening fraction decreased compared with shams. Thapsigargin-induced store depletion increased lung endothelial permeability in shams, but not in fistulas. Permeability increased in both groups after the Ca2+ ionophore A23187 or 14,15-epoxyeicosatrienoic acid, independent of store depletion. A diacylglycerol analog had no impact on permeability. Increased distance between the endoplasmic reticulum and the plasmalemmal membrane was ruled out as a mechanism for the loss of the permeability response to store depletion. Endothelial expression of the endoplasmic reticulum Ca2+ ATPase was not altered in fistulas compared with shams, whereas the store-operated canonical transient receptor potential channels 1, 3, and 4 were downregulated in extraalveolar vessel endothelium.

Conclusions: We conclude that the adaptive mechanism limiting store depletion-induced endothelial lung injury in the aortocaval model of heart failure involves downregulation of store-operated Ca2+ channels.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8,11,14-Eicosatrienoic Acid / analogs & derivatives
  • 8,11,14-Eicosatrienoic Acid / pharmacology
  • Animals
  • Calcimycin / pharmacology
  • Calcium Channels / drug effects
  • Calcium Channels / metabolism*
  • Calcium-Transporting ATPases / metabolism
  • Disease Models, Animal
  • Endothelium / drug effects
  • Endothelium / metabolism
  • Enzyme Inhibitors / pharmacology*
  • Heart Failure / metabolism*
  • Ionophores / pharmacology
  • Lung / drug effects
  • Lung / metabolism*
  • Permeability / drug effects
  • Rats
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Thapsigargin / pharmacology*
  • Tissue Culture Techniques
  • Vasodilator Agents / pharmacology

Substances

  • Calcium Channels
  • Enzyme Inhibitors
  • Ionophores
  • Vasodilator Agents
  • Calcimycin
  • Thapsigargin
  • 14,15-epoxy-5,8,11-eicosatrienoic acid
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Calcium-Transporting ATPases
  • 8,11,14-Eicosatrienoic Acid